VistaGen Therapeutics, Inc.

Q3 2025 13F Holders

Symbol
VTGN
CUSIP
92840H400
Type
Equity
Class
COM
Num filings
67
Total reported value, excl. options
$83.7 M
Manager Report Date Value ($000) Shares Option Type